Do you know the early signs of hair loss? And when does hair loss require medical attention? Get better results for treating hair loss by identifying it early.
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that it enrolled the first patient in its Phase 1/2a clinical prostate study. Adamis’ drug, APC-100, will be used to treat men with castrate-resistant prostate
A positive test result for a banned medicinal drug has suddenly shut down Jonathon Millar’s rising equestrian show jumping career and could play havoc with his hopes of competing in his first Summer Olympics in London in 2012.
Canadian show jumping rider Jonathon Millar will appeal the positive drug test that has put his goal of competing in his first Summer Olympic Games in jeopardy.
Adamis Pharmaceuticals Corporation announced today that it enrolled the first patient in its Phase 1/2a clinical prostate study. Adamis' drug, APC-100, will be used to treat men with castrate-resistant prostate cancer.